期刊
JOURNAL OF TOXICOLOGICAL SCIENCES
卷 34, 期 4, 页码 427-431出版社
JAPANESE SOC TOXICOLOGICAL SCIENCES
DOI: 10.2131/jts.34.427
关键词
Histamine H4 receptor; Substance P; JNJ7777120; Pruritus; Keratinocytes
类别
Many medicines exist which can cause pruritus (itching) as serious adverse events. Many severe pruritic conditions respond poorly to histamine H I receptor antagonists; there is no generally accepted antipruritic treatment. Recently described histamine H4 receptors are expressed in haematopoietic cells and have been linked to the pathology of allergy and asthma. We previously reported their expression in human dermal fibroblasts; in this study we have investigated H4 receptor expression in human epidermal tissue and found it to be greater in keratinocytes in the epidermal upper layer than in the lower layer. We have also investigated the effect of histamine H4 receptor antagonists on histamine H I receptor antagonist-resistant pruritus using a mouse model. Scratching behavior was induced by histamine (300 nmol) or substance P (100 nmol) injected intradermally into the rostral part of the back of each mouse. Fexofenadine, a histamine H I receptor antagonist, reduced scratching induced by histamine but not by substance P, whereas JNJ7777120, a histamine H4 receptor antagonist, significantly reduced both histamine- and substance P-induced scratching. These results suggest that H4 receptor antagonists may be useful for treatment of H I receptor antagonist-resistant pruritus.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据